Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Comments

TSLP-the initiator or the terminator of inflammation?

Krishna Ganti
Published February 25, 2025

Related article: T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions


Deciphering the immune signature of SepSecs-specific CD4 T cells in autoimmune hepatitis: what do we know and what remains to be done?

Amédée Renand
Published February 25, 2025

Related article: Elucidating the role of autoreactive T cells and B cells in autoimmune hepatitis


QFL T cells in earlier literature

Ellen Robey
Published July 19, 2024

Related article: A narrow T cell receptor repertoire instructs thymic differentiation of MHC class Ib–restricted CD8+ regulatory T cells


What is the real impact of the RTS,S malaria vaccine?

Lode Schuerman
Published February 28, 2022

Related article: RTS,S: the first malaria vaccine


Endometriosis patients deserve access to quality care

Heather Guidone
Published October 19, 2021

Related article: Rethinking endometriosis and pelvic pain


Treating persisting intestinal SARS-CoV-2 infection to prevent MIS-C – a role for GS-441524?

Martin Alberer
Published June 8, 2021

Related article: Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier


The Time is Now to Amplify Women and BIPOC Experts to Address Vulnerable Populations with Vaccine Hesitancy

Jacelyn Peabody Lever
Published May 7, 2021

Related article: America’s deadly flirtation with antiscience and the medical freedom movement


Chemical pancreatectomy for chronic pancreatitis: a very long way ahead until clinical application

Ihsan Ekin Demir
Published February 12, 2021

Related article: Chemical pancreatectomy treats chronic pancreatitis while preserving endocrine function in preclinical models


Targeting CD8+ T Cells in the Brain: A Promising Adjunctive Therapy Strategy for Cerebral Malaria

Ya ZHAO
Published January 14, 2021

Related article: CD8+ T cells target cerebrovasculature in children with cerebral malaria


Adipose tissue oxygenation and metabolic health in obesity: Time to move from association to causation?

Gijs H. Goossens
Published December 10, 2020

Related article: Decreased adipose tissue oxygenation associates with insulin resistance in individuals with obesity


Clinical implications of cross-reactivity towards SARS-CoV-2.

JOSE R. SECO VASCO
Published November 16, 2020

Related article: Recent endemic coronavirus infection is associated with less-severe COVID-19


NETotic neutrophils release extracellular vesicles that may contribute to the pro-thrombotic conditions in patients with COVID-19

Ming-Lin Liu
Published August 28, 2020

Related article: Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis


Fc receptor Signaling from Immune Complexes Drives Th1 Expansion

Anil Chauhan
Published July 10, 2020

Related article: A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity


Weight loss following RYGB, a result from resetting gut-brain axis and taste-related reward circuit?

Xiaojuan Zhang
Published July 9, 2020

Related article: Taste-related reward is associated with weight loss following bariatric surgery


Implication of HLA-G/receptor signaling in impairment of immune responses in COVID-19 patients

Wei-Hua Yan
Published July 9, 2020

Related article: Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent


Should antibiotics be regularly administered before liver transplantation?

Francesco Paolo Russo
Published July 9, 2020

Related article: Antibiotic pretreatment alleviates liver transplant damage in mice and humans


Is the immune suppression induced by SARS-Cov2 amenable to treatment?

Nicholas Bennett
Published May 26, 2020

Related article: Clinical and immunological features of severe and moderate coronavirus disease 2019


BTK promotes NLRP3 inflammasome activation - and acts as rheostat?

Alexander Weber
Published March 23, 2020

Related article: Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β–mediated colitis


Comment on: The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors

Sujoy Khan
Published March 13, 2020

Related article: The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors


Pitfalls of prediction algorithms in predicting genetic variants of autosomal dominant diabetes: a case of misquotation.

Serena Pezzilli
Published February 21, 2020

Related article: Prediction algorithms: pitfalls in interpreting genetic variants of autosomal dominant monogenic diabetes


← Previous 1 2 3 … 10 11 Next →
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts